A
A

AstraZeneca


Balita

European stocks rise past two-week highs on earnings optimism

* STOXX 600 on course for weekly gains * Chip stocks boosted by TSMC results * Publicis up on outlook hike (New throughout, updates prices, market activity and comments to close) By Sruthi Shankar and Susan Mathew Oct 14 (Reuters) - European stocks rose on Thursday, hitting the highest in more than two weeks as investors bet a steady economic recov
A
I
L
S
A
G
E
F
U

UK Stocks-Factors to watch on Oct. 11

Oct 11 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening steady on Monday, with futures .FFIc1 marginally down 0.25%. * ASTRAZENECA: AstraZeneca AZN.L said its antibody cocktail, the first protective shot other than vaccines against COVID-19, met its main goals in a late-stage trial, helping reduce severe COVID-19 or death in non-hospitali
A
B
U

UK Stocks-Factors to watch on Oct. 5

Oct. 5 (Reuters) - Britain's futures .FFIc1 were 0.19% higher on Tuesday. * GREGGS: Greggs GRG.L raised its full-year profit outlook after underlying sales in its latest quarter rose 3.5% compared with two years ago despite staffing and supply chain disruption. * ASTRAZENECA: AstraZeneca AZN.L said it had submitted a request with U.S. health regula
A
G
G
U

UK Stocks-Factors to watch on Sept 30

Sept 30 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 21 points higher on Thursday, with futures .FFIc1 marginally up 0.57%. * VIRGIN MONEY: Virgin Money UK VMUK.L will close 31 of its 162 branches in the coming months as more customers shift to online banking, the British bank said on Thursday. * DIAGEO: Johnnie Walker whisky maker Di
A
D
M
U

UK Stocks-Factors to watch on Sept 30

Sept 30 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 21 points higher on Thursday, according to financial bookmakers. * MARKS & SPENCER: Marks & Spencer MKS.L pledged to become net zero in carbon emissions across its own operations, its entire supply chain and its products by 2040, 10 years ahead of a government target for Britain. *
A
M
U

Floundering private sales of vaccines in India deal blow to Russia's Sputnik V

* Private sales account for 6% of inoculations since May * Only about 943,000 Sputnik V doses administered in India * Private sales fall as govt centres give other vaccines for free By Krishna N. Das and Jatindra Dash NEW DELHI, Sept 29 (Reuters) - Some of India's private hospitals have cancelled orders for Russia's Sputnik V vaccine as they strugg
A

Floundering private sales of vaccine in India deal blow to Russia's Sputnik V

By Krishna N. Das and Jatindra Dash NEW DELHI, Sept 29 (Reuters) - Some of India's private hospitals have cancelled orders for Russia's Sputnik V vaccine as they struggle to sell COVID-19 shots amid surging supplies of free doses of other vaccines offered by the government. Some industry officials said low demand and the extremely cold storage temp
A

UK Stocks-Factors to watch on Sept 29

Sept 29 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 2 points higher on Wednesday, with futures .FFIc1 marginally down 0.12%. * NEXT: British clothing retailer Next NXT.L raised its full-year profit outlook for the fourth time in six months as it reported a 5.9% rise in first-half profit on a two-year basis. * SSP: Upper Crust owner S
A
A
N
U

Japan's Shionogi to make 1 mln doses of new 19 treatment by early 2022

TOKYO, Sept 29 (Reuters) - Japan's Shionogi & Co Ltd 4507.T said on Wednesday it plans to make at least 1 million doses of a new antiviral treatment for COVID-19 for domestic use by March 2022. The company plans to submit the drug, a protease inhibitor known as S-217622, for regulatory approval in Japan by the end of this year, Chief Executive Isao
A

Global vaccines project to revamp rules after Britain got more than Botswana

* COVAX assigned early Pfizer shots to vaccination leaders UK, UAE * Dose-sharing methodology doesn't check states' vaccine coverage * Vaccine alliance Gavi is proposing changes - internal document * UK was among few countries that had Pfizer freezers, Gavi says * Gavi began to spend $25 million on cold-chain freezers in August By Francesco Guarasc
A
P
S

Vietnam cuts gap between AstraZeneca vaccine shots in largest city

HANOI, Sept 24 (Reuters) - Vietnam will allow residents to have a smaller gap between AstraZeneca COVID-19 vaccine doses in the country's virus epicentre Ho Chi Minh City, the ministry of health said on Friday. People in the city of around 9 million people can now receive a second dose of the vaccine six weeks after the first, down from between 8 a
A

Sinovac's COVID shot highly effective against serious illness- Malaysia study

KUALA LUMPUR, Sept 24 (Reuters) - Sinovac's SVA.O COVID-19 vaccine is highly effective against serious illness, although rival shots from Pfizer/BioNTech and AstraZeneca showed better protection rates, a large real world study from Malaysia showed. The latest data is a boost to the Chinese firm, whose COVID-19 vaccine has been under growing scrutin
A

British Business - Sept 24

Sept 24 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - British Airways has scrapped plans to revitalise its operations at Gatwick airport and launch a low-cost short-haul airline after it failed to come to an agreeme
A
B

UK Stocks-Factors to watch on Sept 23

Sept 23 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 19 points higher on Thursday, with futures .FFIc1 marginally up 0.65%. * MITCHELLS & BUTLERS: Britain's Mitchells & Butlers Plc MAB.L said sales over the past two months have been above pre-pandemic levels. * ROYAL MAIL: Royal Mail Plc RMG.L forecast a surge in first-half operating
A
G
H
I
M
R
U

Thailand delays plan to re-open cities to tourists until November

BANGKOK, Sept 22 (Reuters) - Thailand has pushed back plans to re-open Bangkok and some other major cities to foreign arrivals until November, due to vaccination rates falling short of targets, a senior official said on Wednesday. Officials earlier this month said they planned Link to welcome vaccinated tourists without quarantine to major cities l
A

UK Stocks-Factors to watch on Sept 21

Sept 21 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 35 points higher on Tuesday, with futures .FFIc1 up 0.77%. * COMPASS: Compass Group CPG.L forecast fourth-quarter revenues slightly above expectations as sports fans throng stadiums again and students come back to campuses. * SIG: Building materials supplier SIG Plc SHI.L said that
A
C
J
K
U

Thailand to try alternative 19 vaccination method to stretch supplies

By Panarat Thepgumpanat and Chayut Setboonsarng BANGKOK, Sept 20 (Reuters) - Doctors in Thailand have been given the go-ahead to start giving COVID-19 booster shots under the skin, rather than injecting them into muscles, officials said on Monday, in an effort to strengthen immunity and stretch vaccine supplies. Health Minister Anutin Charnvirakul
A
P

Panama to hand out AstraZeneca vaccines to visitors in tourism push

PANAMA CITY, Sept 15 (Reuters) - Panama approved a plan on Wednesday to vaccinate visitors in a bid to boost a tourism industry badly hit by the coronavirus pandemic, becoming the first Central American nation to offer vaccine doses to tourists. Tourists will receive AstraZeneca AZN.L vaccines, with the recommended interval between the two doses se
A

Sinovac to trial 19 vaccine in South African children as part of global study

JOHANNESBURG, Sept 9 (Reuters) - China's Sinovac Biotech SVA.O will trial its COVID-19 vaccine in children and adolescents in South Africa as part of a global Phase III study, Sinovac and local partner Numolux Group said on Thursday. The study will evaluate the efficacy, immunogenicity and safety of the CoronaVac vaccine on children and adolescents
A
P

UK approves 19 boosters but final decision on programme still pending

* MHRA gives go-ahead for Pfizer, AZ booster shots * Final decision on programme still pending * Debate over if and when boosters will be needed By Alistair Smout LONDON, Sept 9 (Reuters) - Britain's medical regulator on Thursday gave the go-ahead for Pfizer PFE.N and AstraZeneca's AZN.L COVID-19 vaccine to be used as booster shots, but said any de
A
P



Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Gumagamit kami ng cookies para mabigyan ka ng mahusay na karanasan sa aming website. Magbasa pa o palitan ang iyong cookie settings.

Babala sa Risk: Ang iyong kapital ay maaaring malugi. Ang mga produktong naka-leverage ay maaaring hindi para sa lahat. Tingnan ang aming Risk Disclosure.